New Phase Research and Development — Knoxville, Tennessee

New Phase Research and Development is a clinical research site located in Knoxville, Tennessee, United States 37909.

Crixeo Health Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.

New Phase Research and Development has participated in 20 clinical trials with 6 currently active.

Therapeutic areas: Diabetic Peripheral Neuropathy, Seasonal Allergic Rhinitis, Obesity.

Sponsors: Eli Lilly and Company, Padagis LLC, Millennium Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 81/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New Phase Research and Development?

New Phase Research and Development has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New Phase Research and Development conducted?

New Phase Research and Development has 20 clinical trials on record, with 6 currently active. Their work covers Diabetic Peripheral Neuropathy, Seasonal Allergic Rhinitis, Obesity.

Is New Phase Research and Development accredited by Crixeo Health?

Yes — New Phase Research and Development holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about New Phase Research and Development?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.